BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9335253)

  • 1. Estrogen and progesterone receptors in breast cancer.
    Couch P
    Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
    Wallace ML; Smoller BR
    Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
    Langel DJ; Yeatts RP; White WL
    Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
    Frolik D; Caduff R; Varga Z
    Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
    Radhi JM
    Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].
    Fornelli A; Bacci A; Collina G; Eusebi V
    Pathologica; 1995 Oct; 87(5):506-12. PubMed ID: 8868176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apocrine ductal carcinoma in-situ with an unusual morphological presentation.
    Coyne JD
    Histopathology; 2001 Mar; 38(3):280. PubMed ID: 11260313
    [No Abstract]   [Full Text] [Related]  

  • 9. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
    Chen JH; Nalcioglu O; Su MY
    Ann Oncol; 2008 May; 19(5):1024-6. PubMed ID: 18375524
    [No Abstract]   [Full Text] [Related]  

  • 10. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
    Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
    Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous carcinoma of the eyelid. An immunohistochemical study.
    Carson HJ; Gattuso P; Raslan WF; Reddy V
    Am J Dermatopathol; 1995 Oct; 17(5):494-8. PubMed ID: 8599456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cholecystitis as a presentation of metastatic breast carcinoma of the gallbladder: a case report.
    Boari B; Pansini G; Pedriali M; Cavazzini L; Manfredini R
    J Am Geriatr Soc; 2005 Nov; 53(11):2041-3. PubMed ID: 16274401
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serous cystadenocarcinoma of the ovary with simultaneous breast metastases. Description of a case].
    Manini C; Pietribiasi F; Sapino A; Donadio S
    Pathologica; 1998 Apr; 90(2):152-5. PubMed ID: 9619059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein.
    Ormsby AH; Snow JL; Su WP; Goellner JR
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
    Ubillos N; Vola M; Mazzei ME; Magliano J
    Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.
    Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F
    Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137
    [No Abstract]   [Full Text] [Related]  

  • 19. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.
    Bentz JS; Yassa N; Clayton F
    Mod Pathol; 1998 Sep; 11(9):814-22. PubMed ID: 9758360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
    Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
    Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.